Carregant...

Potential Therapeutic Targets and Promising Agents for Combating NAFLD

Nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), is a growing cause of liver cirrhosis and liver cancer worldwide because of the global increases in obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus. Contrary to the advancements in therapies fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Atsushi Umemura, Seita Kataoka, Keiichiro Okuda, Yuya Seko, Kanji Yamaguchi, Michihisa Moriguchi, Takeshi Okanoue, Yoshito Itoh
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2022-04-01
Col·lecció:Biomedicines
Matèries:
HCC
HSC
Accés en línia:https://www.mdpi.com/2227-9059/10/4/901
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!